National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search  E-Mail This Search
Clinical Trial Questions?
Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 208 for your search:
Cancer Type/Condition:  Leukemia, acute myeloid (AML), child
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 to 60
Sponsor: Other
Protocol IDs: MK1-95, NCT00180102
2.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 16 to 65
Sponsor: Other
Protocol IDs: MCC-14178, NCT00361140
3.
Phase: Phase IV
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: SCT 0208, NCT00679536
4.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 4 to 70
Sponsor: Other
Protocol IDs: RPCI-RP-9815, NCI-V99-1527, NCT00003816, RP 98-15
5.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: BfArM 4022064, DKH 50-2728, NCT00111345
6.
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Levosta-CBF-02/04, NCT00215007
7.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 35 and under
Sponsor: Other
Protocol IDs: 0005M52481, MT2000-12, 2000LS040, NCT00176839
8.
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480
9.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 12 to 55
Sponsor: Pharmaceutical / Industry
Protocol IDs: GC P#02.01.001, NCT00469729
10.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 4 and over
Sponsor: NCI
Protocol IDs: RPCI-I-72806, I 72806, NCT00536601
11.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: IAPLSG2004, BT/PR4460/Med/14/531/2003, NCT00517712
12.
Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: UMN-MT2006-13, MT2006-13, NCT00630565
13.
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 0 to 18
Sponsor: Other
Protocol IDs: CHU-0060, NCT01007617
14.
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI
Protocol IDs: FHCRC-1813.00, 5666, NCT00075478
15.
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: P030441, AOM 03142, NCT00149162
16.
Phase: Phase III
Type: Treatment
Status: Active
Age: 17 and under
Sponsor: Other
Protocol IDs: TRIAL, TRIAL Relapsed AML 2001/01, NCT00186966
17.
Phase: Phase III
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: AMLCG 99, BMBF 01 GI 02070, NCT00266136
18.
Phase: Phase III
Type: Treatment
Status: Active
Age: 65 and under
Sponsor: NCI, NHLBI
Protocol IDs: FHCRC-1992.00, 6170, NCT00322101, NHLBI-K23-HL084054-01A1
19.
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 30
Sponsor: NCI
Protocol IDs: COG-AAML0531, AAML0531, NCT00372593
20.
Phase: Phase III
Type: Treatment
Status: Active
Age: Under 4 at diagnosis
Sponsor: NCI
Protocol IDs: COG-AAML0431, AAML0431, NCT00369317
21.
Phase: Phase III
Type: Treatment
Status: Active
Age: 16 to 65
Sponsor: NCI
Protocol IDs: CBMTG-0601, NCT00438958
22.
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 12 to 65
Sponsor: Other
Protocol IDs: PROGAST, NCT00180089
23.
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, NHLBI
Protocol IDs: 467, BMT CTN 0501, 5 U01 HL69294-05, NCT00412360
24.
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 65 and under
Sponsor: Other
Protocol IDs: 2005-0366, NCT00469144
25.
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Other
Protocol IDs: NOPHO-AML 2004, NCT00476541
1     
New Search

Having trouble with this form? Check the help page or contact an NCI information specialist through LiveHelp online text chat or by calling 1-800-4-CANCER.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov